Sunday, July 11, 2021 4:05:51 PM
Misiu. All due respect. Nader admitted in the ProActive Video last week that the RTF was due to a poor submission report by CYDY and poor RO analysis and dosing report.
This also substantiates my prior claims that RO was always known by Cydy; it was in the BLA, contrary to claims it was added later by FDA.
This video contradicts all NP’s prior comments on the failure of the HIV BLA.
He has also ALWAYS said FDA has been very helpful and for people to basically get off FDA’s back.
Was/is NP lying about all of this regarding the FDA?
If FDA was being obstructive, why would Nader constantly lie about this, and complement , instead of just Never Commenting on FDA?
He gets no extra credit to complement FDA, they could care less about a Nader complement. They do care when he lies about trial results and they said so in a very public PR.
There has never been 3rd party confirmation on these type of claims regarding FDA changing things. In fact these claims regarding HIV are completely repudiated by Nader last week.
Is NP practicing his lying or just lying because that is what he does? Or has he always been telling the truth about FDA? One of these comments is true.
I know It is difficult to follow due to all the other lies.
This also substantiates my prior claims that RO was always known by Cydy; it was in the BLA, contrary to claims it was added later by FDA.
This video contradicts all NP’s prior comments on the failure of the HIV BLA.
He has also ALWAYS said FDA has been very helpful and for people to basically get off FDA’s back.
Was/is NP lying about all of this regarding the FDA?
If FDA was being obstructive, why would Nader constantly lie about this, and complement , instead of just Never Commenting on FDA?
He gets no extra credit to complement FDA, they could care less about a Nader complement. They do care when he lies about trial results and they said so in a very public PR.
There has never been 3rd party confirmation on these type of claims regarding FDA changing things. In fact these claims regarding HIV are completely repudiated by Nader last week.
Is NP practicing his lying or just lying because that is what he does? Or has he always been telling the truth about FDA? One of these comments is true.
I know It is difficult to follow due to all the other lies.
3X
God Bless America!
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
